155 related articles for article (PubMed ID: 3079936)
1. Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Clinical perspective.
Smith JA
Urology; 1986 Jan; 27(1 Suppl):9-15. PubMed ID: 3079936
[TBL] [Abstract][Full Text] [Related]
2. Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.
Garnick MB
Urology; 1986 Jan; 27(1 Suppl):21-8. PubMed ID: 3079935
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
[TBL] [Abstract][Full Text] [Related]
4. Leuprolide versus diethylstilbestrol for metastatic prostate cancer.
Leuprolide Study Group
N Engl J Med; 1984 Nov; 311(20):1281-6. PubMed ID: 6436700
[TBL] [Abstract][Full Text] [Related]
5. The sustained release of LH X RH agonist from LH X RH agonist-polymer composite in patients with prostatic cancer.
Imai K; Yamanaka H; Yuasa H; Yoshida M; Asano M; Kaetu I; Yamazaki I; Suzuki K
Prostate; 1986; 8(4):325-32. PubMed ID: 3086853
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
Santen RJ; Warner B
Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
[TBL] [Abstract][Full Text] [Related]
7. Leuprolide: a gonadotropin-releasing hormone analog for the palliative treatment of prostatic cancer.
Wojciechowski NJ; Carter CA; Skoutakis VA; Bess DT; Falbe WJ; Mickle TR
Drug Intell Clin Pharm; 1986 Oct; 20(10):746-51. PubMed ID: 2429815
[TBL] [Abstract][Full Text] [Related]
8. Management of metastatic prostatic cancer.
Paulson DF
Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
[TBL] [Abstract][Full Text] [Related]
9. Hormonal therapy for prostate cancer.
Torti FM
N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
[No Abstract] [Full Text] [Related]
10. DES lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate.
Stein BS; Smith JA
Urology; 1985 Apr; 25(4):350-3. PubMed ID: 3920802
[TBL] [Abstract][Full Text] [Related]
11. A comparison of a powerful luteinizing hormone releasing hormone analogue agonist and estrogen in the treatment of advanced prostatic cancer.
Winfield H; Trachtenberg J
J Urol; 1984 Jun; 131(6):1107-9. PubMed ID: 6427477
[TBL] [Abstract][Full Text] [Related]
12. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate.
Sharifi R; Lee M; Ojeda L; Ray P; Stobnicki M; Guinan P
Urology; 1985 Aug; 26(2):117-24. PubMed ID: 3927551
[TBL] [Abstract][Full Text] [Related]
13. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047
[No Abstract] [Full Text] [Related]
14. Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
Oefelein MG; Cornum R
J Urol; 2000 Sep; 164(3 Pt 1):726-9. PubMed ID: 10953134
[TBL] [Abstract][Full Text] [Related]
15. Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate.
Smith JA
J Urol; 1984 Jun; 131(6):1110-2. PubMed ID: 6427478
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
[TBL] [Abstract][Full Text] [Related]
17. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
[No Abstract] [Full Text] [Related]
18. Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.
Warner B; Worgul TJ; Drago J; Demers L; Dufau M; Max D; Santen RJ
J Clin Invest; 1983 Jun; 71(6):1842-53. PubMed ID: 6408125
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of (D-Leu6)-des Gly-NH2 10-LHRH ethylamide against prostatic cancer.
Yamanaka H; Makino T; Yajima H; Saruki K; Shida K
Prostate; 1985; 6(1):27-34. PubMed ID: 3918298
[TBL] [Abstract][Full Text] [Related]
20. Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
Chodak GW
Urology; 1989 May; 33(5 Suppl):42-4. PubMed ID: 2523610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
